Sigma recorded normalised EBIT growth of 41% in its first post-merger end-of-year results.
Key figures include like-for-like sales growth of 11.3% across the Australian Chemist Warehouse network, which now comprises 588 stores, according to an ASX statement this morning.
“The merger with Chemist Warehouse has delivered a stronger, more integrated healthcare business, with greater scale, capability, and market reach,” said Sigma CEO and Managing Director Vikesh Ramsunder.
“The FY25 results demonstrate the group’s momentum and potential for ongoing growth.
“Normalised EBIT for the year was up 41.4% compared to the prior corresponding period.”
Ramsunder said supply chain reliability and efficiencies were key to the group’s success, with the benefit of scale resulting in reduction of 11% per unit cost to serve.
The group now has 881 franchise stores across Australia, and reported 35 new stores in Australia and internationally.
“Sigma is now a stronger more integrated healthcare business – one with scale, capability, market reach and growth pathways,” Ramsunder said.
“We have just started the journey to fully realise the benefits of the merger.”
More details in today’s issue of Pharmacy Daily.
